Microchip Technology

MCHPNASDAQUSD

THESIS ALERT

Email me when the MCHP thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$62.13
+$1.80 (+2.98%)Today 1M −17.76%
After hours$60.52−2.59%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$60.33
Prior regular-session close from the quote source.
$61.13–$63.78
Regular-session low and high so far today.
12.6M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 4 projected
Projected for 2027-02-04 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$48.52–$105.91
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own MCHP if design-win momentum and margin mix hold.

MCHP price history

Latest price$62.13Today+$1.80 (+2.98%)
MCHP -16.05%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Multi-year OEM design wins and high switching costs keep Microchip’s revenue resilient and convert product cycles into recurring sales rather than one-off chip purchases.HoldingMateriality: High

    FY26 revenue rose to 4,713,100,000 USD from 4,401,600,000 USD in FY25 (evidence of a recovery step). If design wins hold, revenue stays stable or grows and gives predictable cash to fund buybacks/debt reduction; if customers migrate designs away, revenue will decline before margins recover.

    Watch: Large OEMs consolidate designs on competitors (e.g., NXP, ST, TI or integrated SoC providers) and stop selecting Microchip parts.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    FY26 revenue rose to 4,713,100,000 USD from 4,401,600,000 USD in FY25 (evidence of a recovery step).

    Open source ↗
  • A product mix weighted toward differentiated analog and mixed-signal parts supports gross-profit resilience and protects pricing versus commodity MCU suppliers.HoldingMateriality: High

    Gross profit increased to 2,721,100,000 USD in FY26 from 2,467,900,000 USD in FY25 (implying improved product mix or pricing). If mix toward higher-value analog/mixed-signal continues, gross profit and gross margins should stay stable even if unit volumes are lumpy; if mix flips to commoditized products, pricing and gross profit will erode.

    Watch: Aggressive pricing or bundling by large analog/MCU competitors (TI, NXP, Renesas) erodes premium pricing.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Gross profit increased to 2,721,100,000 USD in FY26 from 2,467,900,000 USD in FY25 (implying improved product mix or pricing).

    Open source ↗
  • Modest top-line growth can produce outsized operating-income expansion because Microchip can leverage fixed R&D/SG&A and realize cost discipline after trough volumes.StrengtheningMateriality: Medium

    Operating income rose to 490,100,000 USD in FY26 from 296,300,000 USD in FY25 (operating leverage in action). If operating leverage continues, shareholders get margin expansion and rising free cash flow without large incremental capex; if costs re-accelerate or R&D/M&A spend rises, margin recovery will stall.

    Watch: Management ramps R&D or makes large tuck-in acquisitions that expand operating expense and dilute leverage.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating income rose to 490,100,000 USD in FY26 from 296,300,000 USD in FY25 (operating leverage in action).

    Open source ↗
  • Net income and free-cash generation are volatile and remain sensitive to cycle, product concentration and one-time items, so shareholder returns hinge on disciplined capital allocation (debt reduction, buybacks) rather than reliable EPS compounding.StrengtheningMateriality: Medium

    Net income swung from 1,906,900,000 USD (FY24) to -500,000 USD (FY25) then to 230,000,000 USD (FY26), demonstrating earnings volatility. Volatility means shareholders rely on management’s allocation choices to realize value; poor allocation (bad M&A, high dilution) will destroy value even if revenues recover.

    Watch: Large, value-destroying acquisitions that add debt and impairments (raising interest/expense load).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Net income swung from 1,906,900,000 USD (FY24) to -500,000 USD (FY25) then to 230,000,000 USD (FY26), demonstrating earnings volatility.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Multi-year OEM design wins and high switching costs keep Microchip’s revenue resilient and convert product cycles into recurring sales rather than one-off chip purchases. If design wins hold, revenue stays stable or grows and gives predictable cash to fund buybacks/debt reduction; if customers migrate designs away, revenue will decline before margins recover.

A product mix weighted toward differentiated analog and mixed-signal parts supports gross-profit resilience and protects pricing versus commodity MCU suppliers. If mix toward higher-value analog/mixed-signal continues, gross profit and gross margins should stay stable even if unit volumes are lumpy; if mix flips to commoditized products, pricing and gross profit will erode.

Modest top-line growth can produce outsized operating-income expansion because Microchip can leverage fixed R&D/SG&A and realize cost discipline after trough volumes. If operating leverage continues, shareholders get margin expansion and rising free cash flow without large incremental capex; if costs re-accelerate or R&D/M&A spend rises, margin recovery will stall.

Net income and free-cash generation are volatile and remain sensitive to cycle, product concentration and one-time items, so shareholder returns hinge on disciplined capital allocation (debt reduction, buybacks) rather than reliable EPS compounding. Volatility means shareholders rely on management’s allocation choices to realize value; poor allocation (bad M&A, high dilution) will destroy value even if revenues recover.

All standing thesis claims
Original report summary

design-win momentum and margin mix hold.

Evidence assessed Nov 9, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Microchip Technology

Where the evidence on Microchip Technology stands: Holding on the latest evidence (Nov 9, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.

Bull case: what the evidence supports

  • Multi-year OEM design wins and high switching costs keep Microchip’s revenue resilient and convert product cycles into recurring sales rather than one-off chip purchases.

    sec.gov ↗

  • A product mix weighted toward differentiated analog and mixed-signal parts supports gross-profit resilience and protects pricing versus commodity MCU suppliers.

    sec.gov ↗

  • Modest top-line growth can produce outsized operating-income expansion because Microchip can leverage fixed R&D/SG&A and realize cost discipline after trough volumes.

    sec.gov ↗

  • Net income and free-cash generation are volatile and remain sensitive to cycle, product concentration and one-time items, so shareholder returns hinge on disciplined capital allocation (debt reduction, buybacks) rather than reliable EPS compounding.

    sec.gov ↗

Bear case: what would count against it

  • Large OEMs consolidate designs on competitors (e.g., NXP, ST, TI or integrated SoC providers) and stop selecting Microchip parts.

    sec.gov ↗

  • Aggressive pricing or bundling by large analog/MCU competitors (TI, NXP, Renesas) erodes premium pricing.

    sec.gov ↗

  • Management ramps R&D or makes large tuck-in acquisitions that expand operating expense and dilute leverage.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Microchip Technology

Loading the break-condition record for Microchip Technology.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Microchip Technology filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Microchip Technology filed an SEC 8-K on 2026-08-19: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Microchip Technology filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large OEMs consolidate designs on competitors (e.g., NXP, ST, TI or integrated SoC providers) and stop selecting Microchip parts.
  • Aggressive pricing or bundling by large analog/MCU competitors (TI, NXP, Renesas) erodes premium pricing.
  • Management ramps R&D or makes large tuck-in acquisitions that expand operating expense and dilute leverage.
  • Large, value-destroying acquisitions that add debt and impairments (raising interest/expense load).

MCHP news

Loading headlines…

Financial statements

MCHP income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

MCHP: quick answers

When does Microchip Technology (MCHP) report earnings next?
Microchip Technology's next results are projected for February 4, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
What is MCHP's short interest?
As of October 30, 2026, 36.6M MCHP shares were sold short, 6.72% of its shares outstanding, up 17.0% from the count before. At the stock's average daily volume that is 3.2 days to cover. FINRA publishes the count twice a month. MCHP short interest history
Have members of Congress traded MCHP?
Reports made public in the last 90 days disclose 3 trades in MCHP by 2 filers: 1 purchase and 2 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed MCHP trade
Which well-known investors own MCHP?
4 of the 37 well-known funds tracked here reported MCHP shares in their latest 13F filings. By share of the fund's portfolio: Glenview Capital Management, 0.4%; Soros Fund Management (George Soros), 0.3%; Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios

MCHP in well-known investors’ portfolios

4 of 37 funds reported MCHP shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Glenview Capital Management0.44%$24.2MNewQ2 2026
George SorosSoros Fund Management0.26%$20.8MNewQ2 2026
Ray DalioBridgewater Associates0.10%$25.2M+853.3%Q2 2026
Maverick Capital0.01%$657KNewQ2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.